What is the current Defence Therapeutics (QB) share price?
The current share price of Defence Therapeutics (QB) is US$ 0.80
How many Defence Therapeutics (QB) shares are in issue?
Defence Therapeutics (QB) has 47,650,370 shares in issue
What is the market cap of Defence Therapeutics (QB)?
The market capitalisation of Defence Therapeutics (QB) is USD 38.12M
What is the 1 year trading range for Defence Therapeutics (QB) share price?
Defence Therapeutics (QB) has traded in the range of US$ 0.2732 to US$ 1.452 during the past year
What is the PE ratio of Defence Therapeutics (QB)?
The price to earnings ratio of Defence Therapeutics (QB) is -2.89
What is the reporting currency for Defence Therapeutics (QB)?
Defence Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Defence Therapeutics (QB)?
The latest annual profit of Defence Therapeutics (QB) is CAD -13.19M
What is the registered address of Defence Therapeutics (QB)?
The registered address for Defence Therapeutics (QB) is 1680 - 200 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3L6
What is the Defence Therapeutics (QB) website address?
The website address for Defence Therapeutics (QB) is www.defencetherapeutics.com
Which industry sector does Defence Therapeutics (QB) operate in?
Defence Therapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
